Antifungal drug resistance of pathogenic fungi
DP Kontoyiannis, RE Lewis - The Lancet, 2002 - thelancet.com
Pathogenic fungi have many complex mechanisms of resistance to antifungal drugs.
Information about the clinical, cellular, and molecular factors contributing to antifungal-drug …
Information about the clinical, cellular, and molecular factors contributing to antifungal-drug …
Invasive aspergillosis in 2002: an update
D Kontoyiannis, G Bodey - European Journal of Clinical Microbiology and …, 2002 - Springer
Despite significant advances in the management of immunosuppressed patients, invasive
aspergillosis remains an important life-threatening complication. In the past two decades …
aspergillosis remains an important life-threatening complication. In the past two decades …
British Association of Dermatologists' guidelines for the management of onychomycosis 2014
The clinical signs of tinea unguium are often difficult to distinguish from those of a number of
other infectious causes of nail damage, such as Candida, mould or bacterial infection. 5 …
other infectious causes of nail damage, such as Candida, mould or bacterial infection. 5 …
Antifungal properties of new series of quinoline derivatives
The series of quinoline derivatives were prepared. The synthetic approach, analytical, and
spectroscopic data of all synthesized compounds are presented. All the prepared derivatives …
spectroscopic data of all synthesized compounds are presented. All the prepared derivatives …
Management of candidiasis Management of Candida species infections in critically ill patients
P Eggimann, J Garbino, D Pittet - The lancet infectious diseases, 2003 - thelancet.com
Invasive candidiasis is a feared infection with mortality similar to that of septic shock (40–
60%). Improved knowledge of its pathophysiology and the availability of new compounds for …
60%). Improved knowledge of its pathophysiology and the availability of new compounds for …
In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates
J Meletiadis, JW Mouton, JFGM Meis… - Antimicrobial Agents …, 2003 - Am Soc Microbiol
The in vitro interaction between terbinafine and the azoles voriconazole, miconazole, and
itraconazole against five clinical Scedosporium prolificans isolates after 48 and 72 h of …
itraconazole against five clinical Scedosporium prolificans isolates after 48 and 72 h of …
Updated perspectives on the diagnosis and management of onychomycosis
JM Falotico, SR Lipner - Clinical, Cosmetic and Investigational …, 2022 - Taylor & Francis
Onychomycosis is the most common nail disease encountered in clinical practice and can
cause pain, difficulty with ambulation, and psycho-social problems. A thorough history and …
cause pain, difficulty with ambulation, and psycho-social problems. A thorough history and …
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy
R Baran, A Kaoukhov - Journal of the European Academy of …, 2005 - Wiley Online Library
Background Onychomycosis is a relatively common disease accounting for up to 50% of all
nail disorders and its prevalence rises with age. As onychomycosis is an important medical …
nail disorders and its prevalence rises with age. As onychomycosis is an important medical …
Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to …
WJ Steinbach, DA Stevens… - Clinical Infectious …, 2003 - academic.oup.com
The development of newer antifungal drugs is creating new potential combination therapies
to combat the dismal mortality rate associated with invasive aspergillosis (IA). The efficacy of …
to combat the dismal mortality rate associated with invasive aspergillosis (IA). The efficacy of …
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society …
M Ruhnke, OA Cornely, M Schmidt‐Hieber, N Alakel… - Mycoses, 2020 - Wiley Online Library
Background Invasive fungal diseases remain a major cause of morbidity and mortality in
cancer patients undergoing intensive cytotoxic therapy. The choice of the most appropriate …
cancer patients undergoing intensive cytotoxic therapy. The choice of the most appropriate …